Cardiology

Lipid-lowering drugs save lives, but use decreasing

Lipid-lowering drugs for primary prevention are associated with a significant survival benefit, but use has decreased over time, according to a study published online Nov. 16 in Circulation.

Diabetes

New study advocates remission as therapeutic goal in prediabetes

Prediabetes is a condition that precedes type 2 diabetes and increases the risk of heart attack, kidney and eye disease, and several types of cancer. There is no approved drug therapy for prediabetes. Scientists at the German ...

page 2 from 22